Point72 Asia (Singapore) Pte. Ltd. Merck & Co., Inc. Transaction History

Point72 Asia (Singapore) Pte. Ltd.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$123.8 - $132.96 $3.37 Million - $3.62 Million	-27,218 Reduced 83.98%	5,191 $643 Million
Q1 2024 May 15, 2024	BUY	$113.24 - $131.95 $3.18 Million - $3.71 Million	28,080 Added 648.65%	32,409 $4.28 Billion
Q4 2023 Feb 14, 2024	BUY	$100.18 - $109.02 $433,679 - $471,947	4,329 New	4,329 $472 Million

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $257B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Point72 Asia (Singapore) Pte. Ltd., based on Form 13F filings with the SEC.

Stay updated on Point72 Asia (Singapore) Pte. Ltd. with notifications on news.